These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7872842)

  • 1. Neuroleptic withdrawal in schizophrenic patients.
    Baldessarini RJ; Viguera AC
    Arch Gen Psychiatry; 1995 Mar; 52(3):189-92. PubMed ID: 7872842
    [No Abstract]   [Full Text] [Related]  

  • 2. Why neuroleptic withdrawal in schizophrenia?
    Carpenter WT; Tamminga CA
    Arch Gen Psychiatry; 1995 Mar; 52(3):192-3. PubMed ID: 7872843
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
    Gilbert PL; Harris MJ; McAdams LA; Jeste DV
    Arch Gen Psychiatry; 1995 Mar; 52(3):173-88. PubMed ID: 7872841
    [No Abstract]   [Full Text] [Related]  

  • 4. Risks of withdrawing antipsychotic medications.
    Wyatt RJ
    Arch Gen Psychiatry; 1995 Mar; 52(3):205-8. PubMed ID: 7872847
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.
    Meltzer HY
    Arch Gen Psychiatry; 1995 Mar; 52(3):200-2. PubMed ID: 7872845
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term treatment for lifetime disorders?
    Greden JF; Tandon R
    Arch Gen Psychiatry; 1995 Mar; 52(3):197-200. PubMed ID: 7872844
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.
    Jeste DV; Gilbert PL; McAdams LA; Harris MJ
    Arch Gen Psychiatry; 1995 Mar; 52(3):209-12. PubMed ID: 7872848
    [No Abstract]   [Full Text] [Related]  

  • 9. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
    Kristjansen P
    Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
    [No Abstract]   [Full Text] [Related]  

  • 10. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 11. The early course of schizophrenia and long-term maintenance neuroleptic therapy.
    Nuechterlein KH; Gitlin MJ; Subotnik KL
    Arch Gen Psychiatry; 1995 Mar; 52(3):203-5. PubMed ID: 7872846
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychotic recurrence after antipsychotic discontinuation.
    Zipursky RB
    Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of tardive dyskinesia.
    Raja M
    Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of late-life schizophrenia with neuroleptics.
    Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
    Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol.
    Bobba R
    Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119
    [No Abstract]   [Full Text] [Related]  

  • 16. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.
    Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J
    Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment.
    Perényi A; Frecska E; Bagdy G; Révai K
    Acta Psychiatr Scand; 1985 Nov; 72(5):430-5. PubMed ID: 2868608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping drug treatment in schizophrenia.
    Drug Ther Bull; 1987 Apr; 25(8):31-2. PubMed ID: 2884089
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of relapse in schizophrenia.
    Lieberman JA; Kane JM; Sarantakos S; Gadaleta D; Woerner M; Alvir J; Ramos-Lorenzi J
    Arch Gen Psychiatry; 1987 Jul; 44(7):597-603. PubMed ID: 2886110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.